12:00 AM
Mar 26, 2012
 |  BC Week In Review  |  Company News  |  Other News

Novartis, Massachusetts Institute of Technology chemistry, supply/service news

In 2011, Novartis began building a pilot, multi-purpose, non-GMP, continuous process, drug manufacturing facility in Basel based on flow technology developed at MIT. The technology is intended...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >